Catalent, which was acquired by Novo Nordisk in December, is a leading contract drug manufacturer operating over 30 manufacturing facilities in the U.S. and abroad. The company makes hundreds of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback